President Donald Trump’s pick to lead the U.S. department ofhealth will likely face another round of criticism about his stocktrading and questions about plans to overhaul Obamacare at a crucial Senate committee hearingthat could clear the path for his nomination.
Representative Tom Price, a Georgia Republican, is appearingTuesday before the Senate Finance Committee, the only one thatvotes on whether to send his nomination to the full Senate forconsideration.
At his first hearing last week before the Senate healthcommittee, Price was grilled by Democrats who have called for aninvestigation into his investments in medical stocks while handlinghealth-related legislation. He didn’t provide details on how toreplace Obamacare, a law that expandedcoverage to 20 million people in the U.S. since it was passed in2010.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
